Clinical Trial Update: Near Infrared Fluorescence Imaging With Indocyanine Green [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating near-infrared fluorescence imaging with indocyanine green for solitary pulmonary nodules has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solitary Pulmonary Nodules

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: University of Pittsburgh | Conditions: Solitary Pulmonary Nodules | EARLY_Phase 1 | Status: COMPLETED